10-Q: Cytta Corp. Swings to Profit on Marketable Securities Gain
Quarterly Report
Cytta Corp. reported a significant shift to net income for the six months ended March 31, 2025, primarily driven by a substantial unrealized gain on marketable securities, despite continued limited operational revenue.
Summary
- Reported net income of $5,497,681 for the six months ended March 31, 2025, a significant improvement from a net loss of $(2,047,669) in the prior year period.
- This income was primarily due to a $7,661,898 unrealized gain on the fair value change of marketable securities (Reticulate Micro, Inc. Class A Common Stock).
- Operational revenues remained minimal at $2,498 for the six months ended March 31, 2025, compared to $2,411 in the prior year.
- Total assets increased to $7,526,640 as of March 31, 2025, from $2,175,191 as of September 30, 2024, largely due to the recognition of marketable securities.
- Convertible notes payable significantly decreased to $305,950 from $1,438,950, with $1,133,000 in principal notes converted into Reticulate Micro, Inc. stock during the period.
- Accumulated deficit reduced to $(31,370,211) from $(36,867,892).
- Cash balance decreased to $629,061 as of March 31, 2025, from $1,439,835 as of September 30, 2024.
- Net cash used in operating activities was $(807,774) for the six months ended March 31, 2025.
Sentiment
Score: 3
Explanation: While the company reported a net income due to a significant unrealized gain on marketable securities and improved working capital, its core operational revenue remains negligible, and it continues to face substantial doubt about its ability to continue as a going concern. The identified material weaknesses in internal controls and product development delays further temper any positive sentiment derived from the non-operational gain.
Positives
- Achieved a net income of $5,497,681 for the six months ended March 31, 2025, a substantial improvement from a net loss in the prior year.
- Realized a significant unrealized gain of $7,661,898 on marketable securities (Reticulate Micro, Inc. stock).
- Reduced total liabilities, with convertible notes payable decreasing by over $1.1 million due to conversions into Reticulate Micro, Inc. stock.
- Shifted from a total stockholders' deficit of $(237,444) to positive equity of $6,173,952.
- Operating expenses decreased by $691,921 for the six months ended March 31, 2025, compared to the prior year.
- Working capital improved significantly to $6,139,540 as of March 31, 2025, from a deficit of $(428,754) as of September 30, 2024.
Negatives
- Revenues remain extremely limited at $2,498 for the six months ended March 31, 2025, indicating minimal operational sales.
- Experienced a gross loss of $(34,593) for the six months ended March 31, 2025, compared to a gross profit of $2,411 in the prior year.
- Cash balance decreased by over $810,000 during the six months ended March 31, 2025, to $629,061.
- Incurred a loss of $787,637 on the issuance of Reticulate Micro, Inc. stock for debt conversions.
- The company continues to operate with an accumulated deficit of $31,370,211, raising substantial doubt about its ability to continue as a going concern.
- Disclosure controls and procedures were deemed ineffective due to material weaknesses in internal control over financial reporting.
- Material weaknesses include the lack of an independent Audit Committee and insufficient cash controls (no segregation of duties, no dual signatures on bank accounts).
Risks
- Substantial doubt about the Company's ability to continue as a going concern due to accumulated deficit of $31,370,211 and limited revenues.
- Inability to obtain additional equity and/or debt financing arrangements may prevent funding of capital expenditures, working capital, and other cash requirements.
- Reliance on the fair value of marketable securities (Reticulate Micro, Inc. stock) for financial improvement, which is subject to market fluctuations.
- Ineffective disclosure controls and procedures and material weaknesses in internal control over financial reporting, specifically the lack of an independent Audit Committee and insufficient cash controls, pose risks of material misstatement or fraud.
- The MVP versions of CyttaCOMMS were terminated, and the product requires redesign and additional functionality for enterprise sales, indicating potential delays in revenue generation.
- CyttaCARES is at the MVP stage and requires additional work to reach the Minimum Marketable Product (MMP) stage before live demonstrations, delaying market entry and revenue.
- Cash balances may exceed federally insured limits, with approximately $379,000 in excess of FDIC insurance as of March 31, 2025.
Future Outlook
The Company intends to fund operations through equity and/or debt financing arrangements, acknowledging that current capital and existing resources are insufficient for foreseeable capital expenditures, working capital, and other cash requirements. Management believes its products will enable and empower the world to consume higher quality video anywhere, anytime while providing unparalleled safety and security.
Management Comments
- "The Company intends to fund operations through equity and/or debt financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future."
- "Our inability to generate capital or raise additional funds when required will have a negative impact on our business development and financial results."
- "The Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements."
- "We believe our products will enable and empower the world to consume higher quality video anywhere, anytime while providing unparallelled safety and security."
Industry Context
Cytta Corp. operates in the highly competitive and rapidly evolving fields of video compression, incident management software, and institutional safety systems. The company's focus on ultra-low latency video streaming and real-time situational awareness addresses critical needs in emergency response, security, and enterprise communications. The licensing of its CyttaCOMP technology to Reticulate Micro, Inc. and the development of SaaS-based solutions like CyttaCOMMS and CyttaCARES align with broader industry trends towards cloud-based services and integrated security platforms. However, the minimal operational revenue suggests the company is still in early commercialization stages, lagging behind established players in market penetration and revenue generation.
Comparison to Industry Standards
- The company's revenue of $2,498 for six months is significantly below industry standards for publicly traded software companies, many of which report millions or billions in quarterly revenue (e.g., Microsoft, Salesforce, Zoom).
- The reliance on an unrealized gain from marketable securities for net income, rather than operational revenue, indicates a lack of sustainable core business performance compared to profitable industry peers.
- The reported material weaknesses in internal controls, particularly the absence of an independent Audit Committee and inadequate cash controls, fall short of best practices in corporate governance and financial management observed in mature public companies like Adobe or Palo Alto Networks.
- The termination of the CyttaCOMMS MVP and the need for redesign and additional functionality suggest a slower-than-average product development cycle and market readiness compared to agile software development firms.
- The going concern doubt is a critical red flag, contrasting sharply with the financial stability and robust cash flows typically seen in established technology companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Former CTO | Mr. Collins | N/A | N/A | Co-founder, former Director and President and Treasurer of Reticulate Micro, Inc. |
| Former COO | Mr. Chermak | N/A | N/A | Co-founder, Director and Vice-president and Secretary of Reticulate Micro, Inc. |
| Former Director | Mr. Ansari | N/A | N/A | Co-founder of Reticulate Micro, Inc. |
| President | N/A | COO (SGG World LLC representative) | 2023-10-01 | Appointed by the Board of Directors. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weakness | Lack of an independent Audit Committee; the Board of Directors currently acts in this capacity without an independent financial expert member. | As of March 31, 2025 | Raises substantial doubt about necessary oversight over management's activities and contributes to ineffective disclosure controls and procedures. |
| Internal Control Weakness | Insufficient cash controls, including failure to segregate cash handling and accounting functions, and not requiring dual signatures on bank accounts. | As of March 31, 2025 | Results in a reasonable possibility that a material misstatement of financial statements will not be prevented or detected on a timely basis. |
Legal Proceedings
- None.
Related Party Transactions
- Prepaid expenses related party: $351,091 as of March 31, 2025.
- Related party liabilities: $403,175 as of March 31, 2025, including management fees for CEO ($110,000), CEO bonus ($48,040), and stock to be issued to President and COO ($245,135).
- CEO management fees: $15,000 per month.
- President and COO (SGG World LLC) consulting agreement: $15,000 per month and issuance of 250,000 common shares per month.
- Office rent and expenses for COO: $2,575 per month plus incidental expenses, starting April 2024.
- CYCA Option granted to SGG (related party): option to purchase 10,000,000 common shares at $0.02, expiring July 1, 2025.
- RM Warrant granted to SGG (related party): warrant to purchase 250,000 Reticulate Micro common stock shares at $1.00, expiring July 1, 2025.
- Issuance of 3,000,000 shares of common stock to COO for services (February 2023 through January 2024) on May 8, 2024.
- Issuance of 5,000,000, 15,000,000, and 5,000,000 shares to COO as bonuses on May 11, 2023, July 10, 2023, and September 7, 2023, respectively.
Stakeholder Impact
- Shareholders: Experienced a significant increase in total stockholders' equity due to the unrealized gain on marketable securities, but face ongoing dilution risk from stock-based compensation and potential future equity financing. The going concern warning and ineffective internal controls pose significant risks to shareholder value.
- Creditors (Convertible Note Holders): Many convertible notes were settled by conversion into Reticulate Micro, Inc. stock, reducing the company's debt obligations but potentially shifting risk to the value of RM stock. Remaining note holders face maturity dates in 2025.
- Employees/Management: Management compensation includes significant stock-based components. The identified internal control weaknesses, particularly regarding cash, could impact employee trust and operational integrity.
- Customers: Delays in CyttaCOMMS 2.0 and CyttaCARES MMP development could impact customer acquisition and satisfaction, as existing MVP versions were terminated or require further work.
Next Steps
- Finalize the MMP (Minimum Marketable Product) version of CyttaCOMMS 2.0 for the marketplace.
- Complete additional work on CyttaCARES to bring it to the MMP stage before live school demonstrations.
- Seek equity and/or debt financing arrangements to fund operations, capital expenditures, working capital, and other cash requirements.
- Address material weaknesses in internal controls over financial reporting, including establishing an independent Audit Committee and improving cash controls.
Key Dates
| Date | Description |
|---|---|
| 2006-05-30 | Cytta Corp. incorporated under Nevada laws. |
| 2018-07-19 | Technology Access Agreement by and between Cytta Corp and Michael Collins. |
| 2020-04-01 | Agreement by and between Cytta Corp and Makena Investment Advisors, LLC. |
| 2020-08-27 | Agreement by and between Cytta Corp and Peter Rettman. |
| 2020-09-30 | Share Issuance agreement by and between Cytta Corp and United Financial Inc. |
| 2020-09-30 | Amended and Restated Certificate of Designation of Series D Preferred Stock filed. |
| 2020-10-25 | Sublease Agreement by and between Cytta Corp and Michael Collins. |
| 2021-06-02 | Certificate of Designation for Series E Preferred Stock filed. |
| 2021-06-10 | Amendment to Certificate of Designation for Series E Preferred Stock. |
| 2021-11-24 | Certificate of Designation for Series F Preferred Stock filed. |
| 2022-06-22 | Reticulate Micro, Inc. (RM) formed. |
| 2022-08-09 | Intellectual Property License Agreement (IPLA) signed with Reticulate Micro, Inc. |
| 2023-01-01 | CEO monthly fee set at $15,000. |
| 2023-02-01 | Consulting Executive Officer Agreement with SGG World LLC (COO) effective. |
| 2023-02-01 | Option to SGG to purchase 10,000,000 common shares granted. |
| 2023-02-01 | Warrant to SGG to purchase 250,000 RM common stock shares granted. |
| 2023-02-08 | Investor acquired warrant to purchase 2,000,000 common shares and 100,000 RM shares. |
| 2023-02-10 | Warrant to purchase 2,000,000 common shares and 100,000 RM shares issued to a shareholder. |
| 2023-03-01 | Investor acquired warrant to purchase 2,000,000 common shares and 100,000 RM shares. |
| 2023-03-03 | Consulting Agreement with an investor for 2,000,000 common shares, option for 10,000,000 common shares, and warrant for 250,000 RM shares. |
| 2023-03-03 | Warrant to purchase 2,000,000 common shares and 100,000 RM shares issued to a shareholder. |
| 2023-03-31 | March 2023 Notes issued (aggregate $160,000 principal). |
| 2023-04-01 | Consulting Agreement for marketing services (250,000 restricted common stock) entered. |
| 2023-05-11 | 5,000,000 shares issued to COO as bonus. |
| 2023-05-15 | Mr. Collins cancelled 1,600,000 Class B RM shares for 200,000 Class A RM shares. |
| 2023-07-10 | 15,000,000 shares issued to COO as bonus. |
| 2023-09-01 | COO monthly fee increased to $15,000. |
| 2023-09-07 | 5,000,000 shares issued to COO as bonus. |
| 2023-10-01 | COO appointed as President. |
| 2023-10-01 | One-year Agreement for Board of Advisor Services (3,000,000 common stock) entered. |
| 2023-11-30 | 1,887,750 shares issued for accounts payable and accrued interest. |
| 2023-12-06 | Agreement to issue additional 6,000,000 common shares. |
| 2023-12-14 | 6,000,000 shares issued for services. |
| 2023-12-31 | December 2023 Notes issued ($40,000 principal). |
| 2024-01-01 | One-year Consulting Agreement for market awareness (3,000,000 common stock) entered. |
| 2024-01-02 | One-year Consulting Agreement for market awareness ($10,000/month + 5,000,000 common stock) entered. |
| 2024-01-12 | 2,227,661 shares issued for payment of accounts payable and accrued interest. |
| 2024-01-18 | 5,000,000 shares issued for market awareness services. |
| 2024-03-31 | March 2024 Notes issued (aggregate $517,500 principal). |
| 2024-04-01 | Agreement for Board of Advisor Services (5,000,000 common stock + RM stock warrant) entered. |
| 2024-04-01 | Warrant to purchase 50,000 RM Stock shares issued. |
| 2024-04-23 | Agreement for Board of Advisor Services (3,000,000 common stock) entered. |
| 2024-04-23 | Agreement for Board of Advisor Services (5,000,000 common stock) entered. |
| 2024-05-01 | Amendment to October 1, 2023, Board of Advisor Services agreement (7,000,000 shares) effective. |
| 2024-05-08 | 3,000,000 common shares issued for COO services (February 2023 through January 2024). |
| 2024-05-08 | 2,500,000 common shares issued for Board of Advisor Services (Initial Issuance). |
| 2024-05-08 | 1,500,000 common shares issued for Board of Advisor Services. |
| 2024-05-08 | 2,500,000 common shares issued for Board of Advisor Services. |
| 2024-05-16 | 5,000,000 shares issued for Board of Advisor Services (immediately earned). |
| 2024-06-30 | June 2024 Notes issued (aggregate $1,910,950 principal). |
| 2024-09-30 | September 2024 Notes issued (aggregate $125,000 principal). |
| 2025-01-23 | 180,000 restricted common stock shares issued for $4,500 accrued interest. |
| 2025-01-27 | 180,000 restricted common stock shares issued for $4,500 accrued interest. |
| 2025-01-30 | Initial fair value of 2,664,609 RM shares recorded at $9,992,284 ($3.75/share). |
| 2025-03-31 | End of reporting period for this 10-Q. |
| 2025-05-31 | Maturity date for $60,000 principal of March 2023 Notes and December 2023 Note. |
| 2025-06-30 | Maturity date for June 2024 Notes. |
| 2025-07-01 | Maturity date for $100,000 principal of March 2023 Notes. |
| 2025-07-01 | Expiration date for CYCA Option and RM Warrant granted to SGG. |
| 2025-07-01 | Expiration date for various common stock and RM stock warrants. |
| 2025-09-30 | Maturity date for September 2024 Notes. |
| 2025-09-30 | Filing date of this 10-Q. |
Recommendation
sellDespite reporting a net income and a positive shift in stockholders' equity, these improvements are almost entirely attributable to an unrealized gain on marketable securities, not sustainable operational performance. The company's core business generates negligible revenue, operates at a gross loss, and continues to burn cash from operations. The explicit 'going concern' warning, coupled with identified material weaknesses in internal controls (lack of independent audit committee, poor cash controls), signals severe underlying financial and governance issues. Future operations are dependent on uncertain equity or debt financing. The product development delays further dampen prospects for near-term operational improvement. A seasoned investor would view the non-operational gain as a temporary anomaly and focus on the fundamental weaknesses, recommending a sell due to high risk and lack of sustainable value creation.
Keywords
Cytta Corp, SEC Filing, 10-Q, Financial Results, Software, Video Compression, Incident Management, School Safety, CyttaCOMMS, CyttaCARES, CyttaCOMP, Reticulate Micro, Marketable Securities, Going Concern, Internal Controls, Financial Technology, SAAS, ISR Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.